GO:0007159 leukocyte cell-cell adhesion: Adhesion Cascade, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007159 (leukocyte cell-cell adhesion) describes the attachment of a leukocyte to another cell via adhesion molecules, a process central to immune surveillance and inflammation.
• The leukocyte adhesion cascade is a multistep sequence of tethering, rolling, activation, firm adhesion, and transmigration that depends on selectins, integrins, and immunoglobulin superfamily ligands.
• CD44 and its sulfation state modulate leukocyte-endothelial adhesion during inflammatory responses.
• Endothelial cell-cell adhesion and signaling are active participants in leukocyte adhesion, not merely a passive barrier.
• Tumor cells can alter endothelial receptor expression to influence leukocyte adhesion, linking this GO term to cancer biology.
• ICAM-1 nanoclusters can regulate hepatic epithelial cell polarity through leukocyte adhesion-independent mechanisms, showing context-dependent functions of adhesion molecules.
Description
Leukocyte cell-cell adhesion (GO:0007159) is the biological process by which a leukocyte attaches to another cell through adhesion molecules. This process is fundamental to immune function, enabling leukocytes to interact with endothelial cells, other leukocytes, and target tissues during inflammation, immune surveillance, and host defense. The term encompasses both homotypic leukocyte-leukocyte interactions and heterotypic leukocyte-endothelial or leukocyte-epithelial adhesion events. Researchers study GO:0007159 because dysregulation of leukocyte adhesion contributes to a wide range of pathologies, including ischemia-reperfusion injury, chronic inflammatory diseases, and cancer progression. The adhesion cascade is not a single event but a coordinated sequence of molecular steps involving selectins, integrins, and immunoglobulin superfamily members. Understanding these steps at the genetic and molecular level is essential for developing targeted therapies that modulate leukocyte recruitment without compromising immune protection.
leukocyte cell-cell adhesion At A Glance
| GO ID | GO:0007159 |
|---|---|
| GO term | leukocyte cell-cell adhesion |
| Ontology | biological_process |
| Synonym | leukocyte adhesion; leukocyte cell adhesion |
| Definition | The attachment of a leukocyte to another cell via adhesion molecules. |
| Major function | Mediates leukocyte recruitment, immune surveillance, and inflammatory responses through adhesion molecule interactions. |
| Key molecular players | Selectins, integrins, immunoglobulin superfamily members (e.g., ICAM-1, VCAM-1), CD44. |
| Associated diseases | Ischemia-reperfusion injury, inflammatory disorders, cancer (e.g., renal cell carcinoma). |
| Research approaches | Flow chamber assays, intravital microscopy, CRISPR knockout/knock-in models, adhesion molecule profiling. |
What Is GO:0007159?
According to the Gene Ontology, GO:0007159 (leukocyte cell-cell adhesion) is defined as the attachment of a leukocyte to another cell via adhesion molecules. This definition captures the essence of a process in which a leukocyte, a type of white blood cell, forms a physical connection with a neighboring cell through specialized surface proteins. The term is synonymous with leukocyte adhesion and leukocyte cell adhesion. It is a biological process that can involve interactions between leukocytes and endothelial cells, epithelial cells, or other leukocytes, and it is distinct from cell-matrix adhesion because the attachment is to another cell rather than to extracellular matrix components.
Why Is leukocyte cell-cell adhesion Important in Cell Biology?
Leukocyte cell-cell adhesion is a cornerstone of immune and inflammatory responses, and its dysregulation is implicated in a broad spectrum of human diseases. The leukocyte adhesion cascade is critical in myocardial ischemia-reperfusion injury, where excessive leukocyte recruitment exacerbates tissue damage. In chronic inflammatory conditions, adhesion molecules such as CD44 and its sulfated forms influence leukocyte-endothelial interactions. Endothelial cells actively participate in this process through cell-cell adhesion and signaling, which can be modulated in disease states. Moreover, tumors such as renal cell carcinoma can alter endothelial receptor expression to promote leukocyte adhesion, suggesting a role in cancer progression and immune evasion. Understanding GO:0007159 therefore has direct implications for developing anti-inflammatory and anti-cancer therapies, as well as for interpreting immune-related experimental models.
• Essential for immune surveillance and host defense by enabling leukocytes to reach sites of infection or injury.
• Central to the pathogenesis of ischemia-reperfusion injury, where leukocyte adhesion worsens tissue damage.
• Modulated by CD44 sulfation, linking glycosylation and inflammation.
• Endothelial cell-cell adhesion and signaling actively regulate leukocyte adhesion.
• Tumor cells can reprogram endothelial receptor expression to influence leukocyte adhesion, affecting cancer immunity.
• ICAM-1 can have leukocyte adhesion-independent roles in epithelial polarity, highlighting context-dependent functions.
• Adhesive dynamics modeling provides quantitative insights into leukocyte adhesion under flow.
• Integrin antagonists are explored as therapeutics to block pathological leukocyte adhesion.
• Relevant to autoimmune diseases, atherosclerosis, and transplant rejection.
• Provides targets for CRISPR-based functional genomics in immunology and oncology.
What Happens During leukocyte cell-cell adhesion?
Tethering and Rolling
In simple terms: The leukocyte first loosely attaches and rolls along the blood vessel wall.
The initial step of leukocyte cell-cell adhesion involves tethering and rolling of leukocytes on activated endothelial cells. This is mediated primarily by selectins (L-selectin, P-selectin, E-selectin) interacting with their carbohydrate ligands, allowing transient adhesive interactions that slow the leukocyte under shear flow. CD44 and its sulfation status can modulate this rolling phase during inflammatory responses. The rolling step is critical for subsequent activation and firm adhesion, and it is a target for anti-inflammatory strategies.
Activation and Firm Adhesion
In simple terms: The leukocyte receives signals that activate its integrins, causing it to stick tightly to the vessel wall.
Following rolling, leukocytes encounter chemokines and other activating signals that trigger inside-out signaling, leading to conformational activation of integrins such as LFA-1 and VLA-4. These activated integrins bind with high affinity to immunoglobulin superfamily ligands on endothelial cells, including ICAM-1 and VCAM-1, resulting in firm adhesion. This step is essential for leukocyte arrest and is regulated by endothelial cell-cell adhesion and signaling. Integrin antagonists can block this firm adhesion, representing a therapeutic approach.
Transmigration and Cell-Cell Interactions
In simple terms: The leukocyte squeezes through the endothelial layer and interacts with other cells in the tissue.
After firm adhesion, leukocytes undergo transmigration across the endothelial barrier, a process that involves additional adhesion molecules such as PECAM-1 and junctional adhesion molecules. Endothelial cell-cell adhesion and signaling are dynamically remodeled to permit leukocyte passage. Once in the tissue, leukocytes can engage in homotypic cell-cell adhesion with other leukocytes or interact with epithelial cells, as seen in hepatic epithelial polarity regulation by ICAM-1 nanoclusters. The entire cascade is finely tuned and can be modeled using adhesive dynamics to predict leukocyte behavior under flow.
Leukocyte-Endothelial Interactions in Disease
In simple terms: In diseases like cancer or ischemia, the adhesion process can become harmful.
In pathological conditions, leukocyte-endothelial interactions can exacerbate tissue injury. For example, in myocardial ischemia-reperfusion injury, excessive leukocyte adhesion contributes to inflammation and tissue damage. Renal cell carcinoma can alter endothelial receptor expression responsible for leukocyte adhesion, potentially affecting immune cell infiltration and tumor progression. These disease-specific alterations highlight the importance of understanding GO:0007159 in translational research.
Key Genes Involved in GO:0007159 leukocyte cell-cell adhesion
The following genes and proteins are key players in leukocyte cell-cell adhesion, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SELL (L-selectin) | Mediates initial tethering and rolling of leukocytes on endothelium | Target for anti-inflammatory therapies; knockout models show impaired leukocyte recruitment |
| SELP (P-selectin) | Stored in endothelial Weibel-Palade bodies; mediates rolling | Rapidly mobilized during inflammation; studied in ischemia-reperfusion |
| SELE (E-selectin) | Expressed on activated endothelium; supports rolling | Induced by cytokines; marker of endothelial activation |
| ITGAL (LFA-1) | Integrin mediating firm adhesion to ICAM-1 | Knockout mice have defective leukocyte adhesion; target for integrin antagonists |
| ITGB2 (CD18) | Beta-2 integrin subunit; partners with LFA-1 | Mutations cause leukocyte adhesion deficiency; studied in immune disorders |
| ITGA4 (VLA-4) | Integrin binding VCAM-1; mediates firm adhesion | Involved in lymphocyte trafficking; target in multiple sclerosis |
| ICAM1 | Immunoglobulin superfamily ligand for LFA-1 | Upregulated in inflammation; nanoclusters regulate epithelial polarity |
| VCAM1 | Ligand for VLA-4; supports leukocyte adhesion | Expressed on activated endothelium; role in atherosclerosis |
| CD44 | Adhesion molecule modulated by sulfation | Influences leukocyte-endothelial adhesion in inflammation |
| PECAM1 (CD31) | Mediates transmigration and endothelial junction integrity | Knockout delays leukocyte transmigration; studied in vascular biology |
| JAM-A | Junctional adhesion molecule; regulates transmigration | Part of endothelial junctions; modulates leukocyte passage |
| CX3CL1 | Chemokine that promotes leukocyte adhesion | Induces integrin activation; studied in neuroinflammation |
| CCL2 (MCP-1) | Chemokine recruiting monocytes | Activates integrins; role in atherosclerosis |
| IL8 (CXCL8) | Chemokine activating neutrophils | Promotes firm adhesion; target in inflammatory diseases |
| TNF | Cytokine inducing endothelial adhesion molecules | Upregulates ICAM-1, VCAM-1, E-selectin; used experimentally |
| IL1B | Cytokine activating endothelium | Induces adhesion molecule expression; models of inflammation |
| NFKB1 | Transcription factor regulating adhesion molecule expression | Central to inflammatory gene programs; knockout models |
| RAC1 | Small GTPase regulating integrin signaling | Modulates cytoskeletal changes during adhesion; studied in leukocytes |
How Is leukocyte cell-cell adhesion Regulated?
Leukocyte cell-cell adhesion is tightly regulated at multiple levels. Inflammatory cytokines such as TNF and IL-1β induce the expression of endothelial adhesion molecules including E-selectin, ICAM-1, and VCAM-1, thereby promoting leukocyte adhesion. Chemokines presented on endothelial surfaces activate leukocyte integrins through inside-out signaling, converting them to a high-affinity state. CD44 sulfation can modulate leukocyte-endothelial adhesion, linking post-translational modifications to adhesion regulation. Endothelial cell-cell adhesion and signaling also dynamically regulate the availability of adhesion ligands and junctional molecules, influencing leukocyte transmigration. Integrin antagonists can disrupt these regulatory pathways, offering therapeutic opportunities.
leukocyte cell-cell adhesion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGB2 | Leukocyte adhesion deficiency | Knockout mice or patient-derived iPSCs with point mutations |
| ICAM1 | Inflammatory diseases, cancer | Knock-in of tagged ICAM1 for imaging; knockout in endothelial cells |
| CD44 | Inflammation, cancer metastasis | Overexpression or sulfation-deficient mutants in leukocytes |
| SELE | Atherosclerosis, ischemia-reperfusion | Endothelial-specific knockout or overexpression |
| VCAM1 | Multiple sclerosis, atherosclerosis | Conditional knockout in endothelium; integrin antagonist testing |
Leukocyte Adhesion in Ischemia-Reperfusion Injury
Myocardial ischemia-reperfusion injury is characterized by an intense inflammatory response in which leukocyte cell-cell adhesion plays a central role. The leukocyte adhesion cascade contributes to tissue damage by promoting leukocyte infiltration and release of cytotoxic mediators. Targeting adhesion molecules has been explored as a therapeutic strategy to reduce reperfusion injury.
Cancer and Altered Leukocyte Adhesion
Renal cell carcinoma can alter endothelial receptor expression responsible for leukocyte adhesion, potentially facilitating immune evasion or modulating anti-tumor immunity. This suggests that leukocyte cell-cell adhesion is not only relevant to inflammation but also to cancer biology, where tumor cells can reprogram the adhesion landscape.
Inflammatory and Immune Disorders
Dysregulated leukocyte adhesion contributes to chronic inflammatory diseases, autoimmune conditions, and leukocyte adhesion deficiency syndromes. CD44 and its sulfation state influence leukocyte-endothelial adhesion during inflammatory responses, highlighting the role of adhesion molecules in disease pathogenesis. Integrin antagonists are being developed to treat such disorders by blocking pathological leukocyte adhesion.
From leukocyte cell-cell adhesion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate leukocyte rolling? | Knockout of selectin or ligand in mice; flow chamber assay |
| What is the role of integrin activation in firm adhesion? | Point mutation in integrin cytoplasmic domain to block inside-out signaling |
| How does CD44 sulfation affect adhesion? | Knock-in of sulfation-deficient CD44; leukocyte-endothelial adhesion assay |
| Can we visualize ICAM-1 nanoclusters? | Tagged knock-in of ICAM1 with fluorescent protein; super-resolution imaging |
| Does endothelial cell-cell adhesion regulate leukocyte transmigration? | Endothelial-specific knockout of junctional molecules; intravital microscopy |
| Can we screen for genes regulating leukocyte adhesion? | CRISPR library screening in leukocytes or endothelial cells under flow |
How to Study the leukocyte cell-cell adhesion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow chamber assay | Leukocyte rolling, adhesion, and transmigration under shear | Testing adhesion molecule function and drug effects |
| Intravital microscopy | Real-time leukocyte-endothelial interactions in vivo | Inflammation and ischemia-reperfusion studies |
| CRISPR knockout screening | Genes required for leukocyte adhesion | Discovery of novel adhesion regulators |
| Adhesive dynamics simulation | Quantitative adhesion parameters | Modeling leukocyte behavior under flow |
| Immunofluorescence | Localization of adhesion molecules | Visualizing ICAM-1 nanoclusters and junctional proteins |
| Western blot | Protein expression of adhesion molecules | Assessing cytokine-induced upregulation |
| Flow cytometry | Surface expression of integrins and selectins | Phenotyping leukocytes and endothelial cells |
| RNA-seq | Transcriptional profiling of adhesion genes | Identifying gene expression changes in inflammation |
Flow Chamber Assays
Flow chamber assays are used to study leukocyte adhesion under controlled shear stress, mimicking physiological blood flow. These assays measure rolling, firm adhesion, and transmigration of leukocytes on endothelial monolayers, and are instrumental in dissecting the adhesion cascade.
Intravital Microscopy
Intravital microscopy allows real-time visualization of leukocyte-endothelial interactions in living animals. This technique has been used to study leukocyte adhesion in ischemia-reperfusion injury and inflammation models.
CRISPR Screening and Functional Genomics
CRISPR library screening enables unbiased identification of genes regulating leukocyte cell-cell adhesion. By knocking out genes in leukocytes or endothelial cells and assessing adhesion under flow, researchers can discover novel adhesion regulators.
Adhesive Dynamics Modeling
Adhesive dynamics is a computational modeling approach that simulates leukocyte adhesion under flow, integrating molecular kinetics and cell mechanics. It provides quantitative predictions of adhesion behavior and has been used to study the role of selectins and integrins.
How CRISPR Can Be Used to Study GO:0007159 leukocyte cell-cell adhesion
Knockout
CRISPR knockout of genes such as ITGB2, ICAM1, or CD44 can abolish specific leukocyte adhesion steps, allowing researchers to determine their causal role. For example, knockout of integrin subunits impairs firm adhesion and is used to model leukocyte adhesion deficiency.
Point Mutation
Point mutations can be introduced to dissect signaling domains or post-translational modification sites. For instance, mutating integrin cytoplasmic tyrosines blocks inside-out signaling, revealing their role in firm adhesion. Similarly, point mutations in CD44 sulfation sites can test the importance of sulfation in leukocyte-endothelial adhesion.
Knock-in
Knock-in of tagged adhesion molecules, such as fluorescently labeled ICAM-1, enables live-cell imaging of nanocluster formation and dynamics. This approach has revealed leukocyte adhesion-independent functions of ICAM-1 in epithelial polarity.
Overexpression
Overexpression of adhesion molecules like CD44 or selectins can enhance leukocyte adhesion and is used to study gain-of-function effects in inflammation and cancer models.
How EDITGENE Supports leukocyte cell-cell adhesion Research
Researchers studying leukocyte cell-cell adhesion-related genes often need to determine whether a candidate gene is causally involved in adhesion, and which domains or modifications are required. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for leukocyte cell-cell adhesion research.
Frequently Asked Questions About leukocyte cell-cell adhesion
What is GO:0007159?
GO:0007159 is the Gene Ontology term for leukocyte cell-cell adhesion, defined as the attachment of a leukocyte to another cell via adhesion molecules.
What genes are involved in leukocyte cell-cell adhesion?
Key genes include SELL, SELP, SELE, ITGAL, ITGB2, ITGA4, ICAM1, VCAM1, CD44, and PECAM1, among others.
What is the leukocyte adhesion cascade?
The leukocyte adhesion cascade is a multistep process of tethering, rolling, activation, firm adhesion, and transmigration that mediates leukocyte recruitment to tissues.
How is leukocyte cell-cell adhesion studied?
Common methods include flow chamber assays, intravital microscopy, CRISPR screening, and adhesive dynamics modeling.
What diseases are associated with leukocyte cell-cell adhesion?
Diseases include ischemia-reperfusion injury, inflammatory disorders, leukocyte adhesion deficiency, and cancer such as renal cell carcinoma.
What is the role of CD44 in leukocyte adhesion?
CD44 and its sulfation state modulate leukocyte-endothelial adhesion during inflammatory responses.
Can CRISPR be used to study leukocyte adhesion?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect gene function in leukocyte adhesion.
What is leukocyte adhesion deficiency?
Leukocyte adhesion deficiency is a rare immunodeficiency caused by mutations in integrin genes such as ITGB2, leading to defective leukocyte adhesion and recurrent infections.
How do endothelial cells regulate leukocyte adhesion?
Endothelial cells express adhesion molecules like ICAM-1 and VCAM-1 and regulate junctional integrity to control leukocyte adhesion and transmigration.
What is adhesive dynamics in leukocyte adhesion?
Adhesive dynamics is a computational modeling approach that simulates leukocyte adhesion under flow by integrating molecular kinetics and cell mechanics.
Conclusion
GO:0007159 (leukocyte cell-cell adhesion) is a fundamental biological process that underpins immune surveillance, inflammation, and tissue repair. The multistep adhesion cascade, involving selectins, integrins, and immunoglobulin superfamily ligands, is tightly regulated and can become dysregulated in diseases ranging from ischemia-reperfusion injury to cancer. Understanding the molecular players and their regulation provides opportunities for therapeutic intervention, and CRISPR-based models are invaluable for dissecting causal mechanisms. As research advances, targeting leukocyte adhesion pathways holds promise for treating inflammatory and malignant diseases.
References
- 1. Gumina RJ et al.. 1997. The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury.. Basic Res Cardiol 92(4):201-13 PMID: 9342427
- 2. Johnson P et al.. 2000. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response?. Biochem Pharmacol 59(5):455-65 PMID: 10660111
- 3. Cerutti C et al.. 2017. Endothelial cell-cell adhesion and signaling.. Exp Cell Res 358(1):31-38 PMID: 28602626
- 4. McIntyre TM et al.. 2003. Cell-cell interactions: leukocyte-endothelial interactions.. Curr Opin Hematol 10(2):150-8 PMID: 12579042
- 5. Juengel E et al.. 2016. Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.. Oncotarget 7(15):20410-24 PMID: 26943029
- 6. Cacho-Navas C et al.. 2024. ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin.. Elife 12 PMID: 38597186
- 7. Hammer DA. 2014. Adhesive dynamics.. J Biomech Eng 136(2):021006 PMID: 24384944
- 8. Curley GP et al.. 1999. Integrin antagonists.. Cell Mol Life Sci 56(5-6):427-41 PMID: 11212296
